The FIB-4 Is a Marker of Monocyte/Macrophage Activation Independently from Severe Hepatic Disease in People Living with HIV on Stable and Successful Treatment
Viruses · 28.07.2026 · 18 (8) · 829
DOI: 10.3390/v18080829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 28.07.2026. Verfasst von Matteo Vassallo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine/Infectious Diseases Department, Cannes Hospital, 06400 Cannes, France. Hauptthemen laut MEDLINE: HIV Infections, Macrophage Activation, Biomarkers, Monocytes. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences (United States), Gilead.
Abstract (Originalsprache)
Objectives
Despite successful antiretroviral treatment (ART), people living with HIV (PWH) continue experiencing chronic immune activation and comorbidities. We analysed whether the Fibrosis 4 index (FIB-4) is associated with monocyte–macrophage activation in PWH with non-severe hepatic disease. Materials and Methods: We performed a cross-sectional analysis about factors associated with monocyte–macrophage activation among PWH either on triple or dual ART. Background measurements, comorbid conditions and FIB-4 values were correlated with plasmatic markers of monocyte–macrophage activation (sCD163 and sCD14) using univariate and linear regression analysis.
Results
We included 366 subjects (age 60.5, 75% male, years of HIV infection 24.5, mean FIB-4 1.52, 8% with FIB-4 > 2.67, Body Mass Index 24.5). In univariate analysis, FIB-4 was associated with older age, years of HIV infection, ART duration, lower CD4/CD8 ratio at inclusion, lower nadir CD4, higher sCD14 and sCD163 values, living alone, dyslipidaemia, high blood pressure and diabetes (p < 0.05 for all). In multivariate analysis FIB-4 ≥ 1.3 was associated with sCD163 values ≥ 782 ng/mL [AdjOR 1.85, 95% CI [1.05; 3.33] p = 0.035], independently from CD4 count, ART duration, living alone, hepatitis C, high blood pressure and alcohol.
Conclusions
The FIB-4 is a simple tool reliable for monocyte–macrophage activation in PWH, able to define subjects with higher risks of complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine/Infectious Diseases Department, Cannes Hospital, 06400 Cannes, France.
- Unité de Recherche Clinique Cote d'Azur (Unité de Recherche Radiologically Isolated Syndrome), Université Côte d'Azur, 06000 Nice, France.
- Public Health Department, UR2CA-RESPECT, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.
- Pain Department and FHU InovPain, 06000 Nice, France.
- Infectious Diseases Department, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.
- Clinical Research Department, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.
ORCID-Profile: Matteo Vassallo, Roxane Fabre, Amandine Pisoni
Förderung
- Gilead Sciences (United States)
- Gilead
Zitieren
APA
Vassallo, M., Fabre, R., Ferrando, S., Chirio, D., Ameil, L., Godemert, M., Naqvi, A., Cua, E., Tuaillon, E., Pisoni, A., Pradier, C., Carles, M., & Durant, J. (2026). The FIB-4 Is a Marker of Monocyte/Macrophage Activation Independently from Severe Hepatic Disease in People Living with HIV on Stable and Successful Treatment. Viruses, 18(8), 829. https://doi.org/10.3390/v18080829
Vancouver
Vassallo M, Fabre R, Ferrando S, Chirio D, Ameil L, Godemert M, et al. The FIB-4 Is a Marker of Monocyte/Macrophage Activation Independently from Severe Hepatic Disease in People Living with HIV on Stable and Successful Treatment. Viruses. 2026;18(8):829. doi:10.3390/v18080829
BibTeX
@article{Vassallo2026,
author = {Vassallo, Matteo and Fabre, Roxane and Ferrando, Sara and Chirio, David and Ameil, Leslie and Godemert, Maeva and Naqvi, Alissa and Cua, Eric and Tuaillon, Edouard and Pisoni, Amandine and Pradier, Christian and Carles, Michel and Durant, Jacques},
title = {The FIB-4 Is a Marker of Monocyte/Macrophage Activation Independently from Severe Hepatic Disease in People Living with HIV on Stable and Successful Treatment},
journal = {Viruses},
year = {2026},
volume = {18},
number = {8},
pages = {829},
doi = {10.3390/v18080829}
}
EUVIMED